Skip to main content

Table 4 Medication use by ethnicity

From: Ethnic differences in the occurrence of acute coronary syndrome: results of the Malaysian National Cardiovascular Disease (NCVD) Database Registry (March 2006 - February 2010)

Medication use Ethnic group    χ2** df  P#
Malays Chinese Indians Others*
Antiplatelets        
Aspirin (%) 6092 (94.4) 2769 (94.1) 2851 (94.2) 649 (95.6) 2.6 3 0.454
Other antiplatelets (%) 4312 (68.5) 2222 (77.0) 2178 (73.0) 440 (73.0) 75.6 3 0.000
Anticoagulants        
Heparin (%) 907 (15.0) 202 (7.3) 281 (9.7) 55 (9.8) 128.9 3 0.000
LMWH (%) 3340 (54.1) 1882 (66.2) 2033 (68.6) 435 (68.5) 282.1 3 0.000
Antihypertensives        
β-blockers (%) 4238 (67.6) 2052 (71.2) 2067 (69.5) 418 (68.9) 12.3 3 0.060
ACEI (%) 3899 (62.4) 1666 (58.4) 1814 (61.1) 337 (55.9) 19.8 3 0.000
ARB (%) 468 (7.8) 242 (8.7) 304 (10.5) 59 (10.4) 20.3 3 0.000
Diuretics (%) 2016 (32.7) 798 (28.3) 888 (30.2) 196 (33.2) 19.8 3 0.000
CCB (%) 895 (14.8) 409 (14.7) 509 (17.4) 82 (14.5) 12.1 3 0.007
Anti-diabetic agents        
OHA (%) 1599 (26.1) 712 (25.4) 1157 (39.3) 112 (19.8) 217.9 3 0.000
Insulin (%) 1522 (24.7) 586 (20.8) 978 (33.1) 104 (18.2) 140.7 3 0.000
Statins        
Statins (%) 5833 (91.0) 2700 (92.1) 2737 (90.8) 646 (95.1) 16.6 3 0.001
  1. Categorical variables are expressed as number (%).
  2. *Others: Indigenous (Orang Asli), Kadazan, Melanau, Murut, Bajau, Bidayuh, Iban (minor ethnic groups) and other non-Malaysians.
  3. **Pearson Chi-Square.
  4. #P value.
  5. LMWH: Low Molecular Weight Heparin.
  6. ACEI: Angiotensin Converting Enzyme Inhibitors.
  7. ARB: Angiotensin Receptor Blockers.
  8. CCB: Calcium Channel Blockers.
  9. OHA: Oral Hypoglycemic Agent.